In silico screening and in vitro biological evaluation reveal Queuine as a promising MAP4K4 inhibitor for treating pancreatic cancer.

ABSTRACT:

SUBMITTER: Kantarci-Carsibasi N 

PROVIDER: S-EPMC12465891 | biostudies-literature | 2025 Sep

REPOSITORIES: biostudies-literature